Is Phenergan Safe in Pregnancy
Status
cautionReason
FDA category C. Limited pregnancy data. Use only if benefit outweighs risk; consult your OB/GYN or prescriber.
Drug Information
Safe Amount
Dosage must be determined by your provider based on individual risk/benefit.
Effects
- Pregnancy
- Should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.
- Mother
- Can cause drowsiness, dizziness, dry mouth, and other sedating effects.
- Baby
- Limited data do not show an increased birth-defect risk above background, but newborn drowsiness or low platelet effect near delivery is possible.
Trimester Notes
- 1st Trimester
- Limited human data. Use only if clearly needed and after provider review.
- 2nd Trimester
- Limited human data. Use only if clearly needed and after provider review.
- 3rd Trimester
- Use caution near delivery. Labeling notes use within 2 weeks of delivery may inhibit platelet aggregation in the newborn.
Risk-Benefit Note
Promethazine may be used in pregnancy when preferred options do not control symptoms, but the dose and need should be reviewed by a clinician.
Conditions & Warnings
- Consult OB/GYN or prescriber
- Prescription drug: review before starting, stopping, or continuing
- May affect pregnancy testing or glucose tolerance testing
Alternatives
- doxylamine-pyridoxine (Diclegis)
- pyridoxine (vitamin B6)
- provider-directed non-drug measures for nausea
References
- FDA label for Phenergan (promethazine HCl)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/07935s030lbl.pdf - MotherToBaby fact sheet on promethazine
https://www.ncbi.nlm.nih.gov/books/NBK582916/ - StatPearls: Promethazine
https://www.ncbi.nlm.nih.gov/books/NBK544361/